Oral tetracycline antibiotic (anti-acne / anti-rosacea)
Pregnancy: Avoid in second and third trimester — dental staining and bone effects in fetus. Use erythromycin or clindamycin topically instead.
Doxycycline 100mg (Acne / Rosacea)
Brand names: Efracea (40mg MR — rosacea), Vibramycin-D, Doxycycline (generic)
Adult dose
Dose: 100 mg once daily
Route: Oral (with food and a full glass of water — reduce oesophageal irritation)
Frequency: Once daily
Max: 100 mg/day for acne/rosacea
Acne vulgaris: 100 mg OD (not BD — BNF recommends 100 mg OD for acne, not the higher infection doses). Minimum course 3 months; may be required 6–12 months. For rosacea (papulopustular): doxycycline 40 mg MR (Efracea) OD — anti-inflammatory dose, not antibiotic. Swallow upright, do not lie down for 30 min post-dose.
Paediatric dose
Route: Oral
Frequency: Once daily
Max: Not recommended in children <12 years (tooth discolouration and bone effects)
Contraindicated in children under 12 years. In children ≥12 years with severe acne: same adult dose 100 mg OD. Avoid concurrent retinoids (raised ICP risk).
Dose adjustments
Renal
No dose adjustment required — unlike many tetracyclines, doxycycline is largely faecally excreted.
Hepatic
Use with caution in hepatic impairment; avoid prolonged use.
Clinical pearls
- BNF acne dose is 100 mg OD — not 100 mg BD (the higher dose is for infections, not acne)
- Combine with topical benzoyl peroxide (e.g., PanOxyl) to prevent C. acnes antibiotic resistance — NICE and BAD recommendation
- Photosensitivity: advise broad-spectrum SPF30+ daily — significant risk in UK summers and abroad
- Oesophageal ulceration prevention: always take with a full glass of water and remain upright for at least 30 min
- For rosacea: Efracea 40 mg MR is a sub-antimicrobial dose — anti-inflammatory action without selecting resistance
Contraindications
- Children under 12 years (dental staining, bone effects)
- Pregnancy (second and third trimester — tooth discolouration)
- Breastfeeding
- Concurrent retinoids (isotretinoin, acitretin) — raised intracranial pressure risk
- Hypersensitivity to tetracyclines
Side effects
- GI upset (nausea, vomiting — take with food)
- Oesophageal ulceration (take with full glass of water, remain upright)
- Photosensitivity (advise sun protection — SPF30+)
- Vaginal candidiasis (prolonged use)
- Pseudotumour cerebri (raised ICP — especially with retinoids)
- Antibiotic resistance (prolonged use — combine with topical benzoyl peroxide to reduce resistance)
Interactions
- Isotretinoin / acitretin — contraindicated (pseudotumour cerebri)
- Antacids (calcium, magnesium, iron, aluminium) — chelation reduces absorption — separate by 2h
- Oral contraceptives — theoretical reduced efficacy (no strong evidence, advise barrier contraception)
- Warfarin — may enhance anticoagulant effect — monitor INR
Monitoring
- Clinical acne response (after 3 months)
- Symptoms of raised ICP (headache, visual changes)
- Photosensitivity reactions
Reference: BNFc; BNF; NICE CG184 Acne Vulgaris; BAD Acne Guidelines 2021; BAD Rosacea Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- Acne Severity Classification (IGA Scale) · Acne
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Revised Original International Autoimmune Hepatitis Score (IAIHG) · Autoimmune Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- FeverPAIN Score for Strep Throat · Throat
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD